Monday, September 8, 2008

8:30 am – 12:00 pm
B1 AM Workshop:
Build a Biorepository from the Ground Up: Practical Measures for Incorporating a Biorepository in Your Organization
Edward S. Kaercher, PMP®, Project Management Office, Merck & Co., Inc.

1:00-4:30 pm
B2 PM Workshop:
Industry Working Group: Creating and Adhering to Standards for Pharmaceutical and Biotech Biorepository Operations to Achieve High Quality Results and Data
Joseph Kessler, Associate Director, Vaccine & Biologics Research, Merck Research Laboratories
Dr F. John Mills, CEO, Biostorage Technologies, Inc.
Karen Pitt, PhD, Special Assistant for Biological Resources, National Cancer Institute

Tuesday, September 9, 2008

11:00 am
Standardization in Biorepositories to Guarantee Accurate Information for Future Sample Usage and Compliance with Current Guidelines
Helen M. Moore, PhD, Biospecimen Research Network Program Manager Office of the Director, National Cancer Institute
Karen Pitt, PhD, Special Assistant for Biological Resources, National Cancer Institute

11:45 am
Innovative Cold Storage Designs That Lower the Operating Cost of a BIOREPOSITORY and Assure Product Safety and Stability
Tom Herdman, Director of Engineering & Product Development, Environmental Specialties (A LUWA Group Company)
Edward Frantz, Director of National Sales, Environmental Specialties (A LUWA Group Company)

Track A: Operational Strategies for Biorepositories

1:30 pm
Establishment of Standard Collection Practices for Sample Viability
Crystal Dotson, Banking Process Expert/Diagnostic and Experimental Medicine, Eli Lilly & Company

3:30 pm
Transfer of Samples from one Biorepository to Another: How do you do it? Where do you start?
Marylee Garvey, Senior Supervisor, Sample Management, Biogen Idec

Track B: Legal and Regulatory Issues Surrounding Biorepositories

3:30 pm
Establish a Chain of Custody for Your Samples to Guarantee Quality
Jennifer Benner, Manager of Quality Systems, Biostorage Technologies, Inc.

Wednesday, September 10, 2008

9:00 am
Pfizer’s Kings Heights Technology Center
Diane Johnson, Associate Director, Pfizer's DNA & Biofluids Center of Emphasis

9:45 am
Development of Novel Storage Technologies to Enhance Sample Collection, Manipulation and Quality
David Wellis, PhD, President & CEO, Genvault Corporation 

3:00 pm
Safety Issues in Biorepositories: Emergency Preparedness Measures to Plan for the Unexpected
Joseph Kessler, Associate Director, Vaccine & Biologics Research, Merck Research Laboratories